Germany Diabetes Market 2020 – With Continuous Glucose Monitoring, Blood Glucose Devices, Insulin Pens, Insulin Pumps, Company Analysis & Forecast Replacement | Instant News


“German Diabetes Market, with Continuous Glucose Monitoring (CGM), Blood Glucose Devices (SMBG), Insulin Pens, Insulin Pumps, Analysis & Forecast of Company Replacement” a report was added to ResearchAndMarkets.com offer. “data-reactid =” 19 “> The “German Diabetes Market, with Continuous Glucose Monitoring (CGM), Blood Glucose Devices (SMBG), Insulin Pens, Insulin Pumps, Analysis & Forecast of Company Replacement” a report was added to ResearchAndMarkets.com offerings.

Diabetes mellitus is a significant public health problem and one of the biggest challenges for the health care system in all of Germany. The prevalence of type 1 & 2 diabetes is known in the German adult population is very high; also, it is considered that a large number of patients have not been diagnosed with this disease. Due to an aging population and an unhealthy lifestyle, the prevalence of type 2 diabetes is expected to continue to increase over the next few years. High-quality care, including adequate monitoring, control of risk factors and active independent management are key factors to prevent costly and burdensome micro and macrovascular complications in German patients with type 2 diabetes. According to this report, the German Diabetes Market is expected to reach USD 12 Billion by end of 2025.

In this report, the German Diabetes market is segmented into four parts; Insulin Pen, CGM, SMBG, and Insulin Pump. All four segments of the insulin delivery devices mentioned above grow from year to year. With the increasing incidence of diabetes problems, various digital treatment solutions have been introduced in this country to help diabetics. The Robert Koch Institute (RKI), the German federal disease control and prevention research institute, has developed a public health surveillance system. It focuses on long-term data, comparable collection and ensures the establishment of an efficient monitoring structure for monitoring relevant diabetes indicators.

In 2019, a nationwide campaign, called Sche1styp ‘, was initiated by a German-based research center, Helmholtz Zentrum Munchen. This campaign addresses the prevention and early detection of type 1 diabetes. In June 2019, the 2nd World Conference on Diabetes and Endocrinology was held in Berlin, which included various research presentations provided by global leaders in the fields of diabetes and endocrinology. Coronavirus disease (COVID-19) has affected the German Diabetes market. For diabetics, it is very important to take precautions to avoid viruses if possible.

This report is titled German Diabetes Market, With Self Monitoring of Blood Glucose Devices (by SMBG, Test Strips, Lancet, Meters, Users & Replacement of Blood Glucose Devices) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensors, Transmitters, CGM Users, Returns) , Insulin Pens (Disposable, Smart & Reusable Insulin Pens, Needle Market, Replacement Policy), Insulin Pump Market, (Insulin Pump Product Differentiation Points, Training Models for Patients & HCP) Companies (Insulet Corporation, B. Braun Melsungen AG , Inc. LifeScan, Artsana SpA, BD, Novo Nordisk A / S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Eli Lilly and Company, Abbott Laboratories) provide a complete analysis of the German Insulin Device Market.

4.1 Growth Drivers

4.1.1 Increased Diabetes Mellitus in an Aging Population

4.1.2 The increasing prevalence of diabetes in various age groups

4.1.3 Increased Government Funding for Diabetes Management

4.1.4 Benefits of Insulin Pump Over Multiple Daily Injection

4.1.5 Treatment Options Compatible with Lifestyle and Technological Advances in Insulin Pump Devices

4.2 Challenges

4.2.1 Technological Advances in Insulin Infusion Devices

4.2.2 Problems of Accuracy of Blood Glucose Meters Recognized by the FDA, Industry & Doctors

4.2.3 Low Compliance Glucose Monitoring & Inadequate Returns for SMBG Supplies

4.2.4 Safety Issues in Insulin Pump Devices

4.2.5 Difficulties Associated with Pumps

4.2.5.1 Weight Gain

4.2.5.2 Diabetic ketoacidosis

4.2.5.3 Infection and Infusion Site Reaction

4.2.6 Compliance

5.1 Market

6.1 Diabetes population

6.1.1 Type 1

6.1.2 Type 2

7.1 By Type

8.1 Germany – CGM market by component

8.1.1 Markets & Forecasts of Glucose Sensors

8.1.2 CGM Transmitter Market & Forecast

8.2 Germany – CGM Users (2011 – 2025)

8.3 Replacement of CGM in Germany

9.1 Market

9.1.1 Type 1 & Type 2 (Diabetes)

9.2 Test and Market Forecast Strips

9.2.1 Type 1 & Type 2 (Diabetes)

9.3 Lancet Markets and Forecasts

9.3.1 Type 1 & Type 2 (Diabetes)

9.4 Meters Market and Forecast

9.4.1 Type 1 & Type 2 (Diabetes)

9.5 Blood Glucose Users and Forecast (SMBG)

9.5.1 Type 1 & Type 2 (Diabetes)

9.6 Reimbursement Costs for Blood Glucose Devices in Germany

10.1 Insulin Pen Users

10.2 Types – Insulin Pen Market & Users

10.2.1 Disposable Insulin Pens

10.2.1.1 Market

10.2.1.2 Users

10.2.2 Reusable Insulin Pens

10.2.2.1 Market

10.2.2.2 Users

10.2.3 Smart Insulin Pens

10.2.3.1 Markets

10.2.3.2 Users

10.3 Insulin Pen Needles Market

10.4 Replacement Policy

11.1 Insulin Pump Market

11.1.1 Type 1 & Type 2 (Market & Forecast of Insulin Pump)

11.2 Insulin Pump Users

11.2.1 Type 1 & Type 2 (Users & Forecast of Insulin Pump)

11.3 Replacement Policy on Insulin Pumps

12.1 Key Players in Insulin Pens

12.1.1 B. Braun Melsungen AG

12.1.2 Eli Lilly and Company

12.1.3 Artsana SpA,

12.1.4 BD

12.1.5 Novo Nordisk A / S

12.1.6 Owen Mumford Ltd.

12.1.7 Ypsomed AG

12.2 Key Players in the Insulin Pump

12.2.1 Medtronic

12.2.2 Insulet companies

12.3 Key Players in SMBG

12.3.1 LifeScan Inc.

12.3.2 Abbott’s Laboratory

12.4 Key Players in CGM

12.4.1 Dexcom Inc

12.4.2 Abbott’s Laboratory

12.4.3 Roche

https://www.researchandmarkets.com/r/sway01“data-reactid =” 118 “> For more information about visiting this report https://www.researchandmarkets.com/r/sway01

View the source version at businesswire.com: https://www.businesswire.com/news/home/20200731005181/en/“data-reactid =” 119 “>View the source version at businesswire.com: https://www.businesswire.com/news/home/20200731005181/en/

[email protected]
For EST Office Hours, Call 1-917-300-0470
For US / CAN Free Calls 1-800-526-8630
For GMT, Office Hours, Telephone + 353-1-416-8900 “data-reactid =” 121 “> ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For EST Office Hours, Call 1-917-300-0470
For US / CAN Free Calls 1-800-526-8630
For GMT, Telephone Business Hours + 353-1-416-8900



image source

to request modification Contact us at Here or [email protected]